ICD-10 Diagnosis Code G70.2

Congenital and developmental myasthenia

Diagnosis Code G70.2

ICD-10: G70.2
Short Description: Congenital and developmental myasthenia
Long Description: Congenital and developmental myasthenia
This is the 2017 version of the ICD-10-CM diagnosis code G70.2

Code Classification
  • Diseases of the nervous system
    • Diseases of myoneural junction and muscle (G70-G73)
      • Myasthenia gravis and other myoneural disorders (G70)

Information for Medical Professionals

Convert to ICD-9 Additional informationCallout TooltipGeneral Equivalence Map
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Acetylcholine resynthesis deficiency
  • Amyotonia congenita
  • Congenital and developmental myasthenia
  • Congenital end-plate acetylcholine receptor deficiency
  • Congenital myasthenia
  • Familial infantile myasthenia
  • Genetically determined myasthenia
  • Myasthenia gravis, juvenile form
  • Pseudomyopathic myasthenia

Information for Patients

Myasthenia Gravis

Myasthenia gravis is a disease that causes weakness in the muscles under your control. It happens because of a problem in communication between your nerves and muscles. Myasthenia gravis is an autoimmune disease. Your body's own immune system makes antibodies that block or change some of the nerve signals to your muscles. This makes your muscles weaker.

Common symptoms are trouble with eye and eyelid movement, facial expression and swallowing. But it can also affect other muscles. The weakness gets worse with activity, and better with rest.

There are medicines to help improve nerve-to-muscle messages and make muscles stronger. With treatment, the muscle weakness often gets much better. Other drugs keep your body from making so many abnormal antibodies. There are also treatments which filter abnormal antibodies from the blood or add healthy antibodies from donated blood. Sometimes surgery to take out the thymus gland helps.

For some people, myasthenia gravis can go into remission and they do not need medicines. The remission can be temporary or permanent.

If you have myasthenia gravis, it is important to follow your treatment plan. If you do, you can expect your life to be normal or close to it.

NIH: National Institute of Neurological Disorders and Stroke

  • Acetylcholine receptor antibody
  • Myasthenia gravis

[Read More]

Congenital myasthenic syndrome Congenital myasthenic syndrome is a group of conditions characterized by muscle weakness (myasthenia) that worsens with physical exertion. The muscle weakness typically begins in early childhood but can also appear in adolescence or adulthood. Facial muscles, including muscles that control the eyelids, muscles that move the eyes, and muscles used for chewing and swallowing, are most commonly affected. However, any of the muscles used for movement (skeletal muscles) can be affected in this condition. Due to muscle weakness, affected infants may have feeding difficulties. Development of motor skills such as crawling or walking may be delayed. The severity of the myasthenia varies greatly, with some people experiencing minor weakness and others having such severe weakness that they are unable to walk.Some individuals have episodes of breathing problems that may be triggered by fevers or infection. Severely affected individuals may also experience short pauses in breathing (apnea) that can lead to a bluish appearance of the skin or lips (cyanosis).
[Read More]
Previous Code
Previous Code G70.1
Next Code
G70.8 Next Code